Activest Wealth Management’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
Other funds holding RNAC
6CM
Activest Wealth Management's RNAC Position: Q3 2026 in Review
Activest Wealth Management held its Cartesian Therapeutics (RNAC) position steady in Q3 2026 at 66 shares worth $476. The position accounts for ﹤0.01% of the portfolio, ranked #905.
Activest Wealth Management first reported a position in RNAC in Q2 2024 and has held it in 10 quarters since. The position peaked at $1.78K in Q2 2024. 100 funds tracked by Wall St. Rank hold RNAC as of Q3 2026.
- Activest Wealth Management held 66 shares of Cartesian Therapeutics worth $476 as of Q3 2026.
- Activest Wealth Management left its Cartesian Therapeutics share count unchanged in Q3 2026.
- Cartesian Therapeutics made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #905 holding.
- Activest Wealth Management first reported a position in Cartesian Therapeutics in Q2 2024 and has held it in 10 quarters since.
- Activest Wealth Management's Cartesian Therapeutics position peaked at $1.78K in Q2 2024.
- 100 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q3 2026.
Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.